Search
for
Sort by
Research 721–750 of 1000+
- PD57-09 NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM SURGICAL RISK CALCULATOR POORLY PREDICTS COMPLICATIONS IN PATIENTS UNDERGOING RADICAL CYSTECTOMY WITH URINARY DIVERSION: THE CASE FOR A PROCEDURE-SPECIFIC RISK CALCULATOR
- Hirsutism
- Adverse Effects and Drug Interactions of Biologic Agents
- Post-Finasteride Syndrome – When will we Get the Courage to Fight the Dictating Pharma Industry – Despite Awareness of “Sexual, Neurological and Metabolic Side Effects in Young Men for Over a Decade”
- Psychosocial Impact of Androgenetic Alopecia
- Androgenetic alopecia: Pathogenesis, clinical features and practical medical treatment
- Extensive Scalp Angioedema following High-Dose Diphenylcyclopropenone for Alopecia Areata
- MORPHOLOGICAL STUDIES ON THE LIPS OF BUFFALO
- The Administration of Ocoxin Increases the Quality of Life of Patients with Advanced Epithelial or Metastatic Ovarian Cancer Undergoing Neoadjuvant Chemotherapy
- Ethylene glycol toxicity in two calves
- Alopecia difusa e atrofia da tireoide associadas à deficiência de selênio e zinco em ovinos.
- Arterial embolization caused by injection of hyaluronic acid (RestylaneR)
- Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society
- Complications of Cushing's syndrome: state of the art
- Multiple sclerosis: Side effects of interferon beta therapy and their management
- A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Acne
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Cross‐Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short‐Time Follow‐Up: Results from the European Network for the Investigation of Gender Incongruence
- Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata
- Enhanced Effect of Platelet-Rich Plasma Containing a New Carrier on Hair Growth
- The Myth of Beneficent Nature: The Risks of Herbal Preparations
- HairMax LaserComb® Laser Phototherapy Device in the Treatment of Male Androgenetic Alopecia
- Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Facial feminization surgery: current state of the art
- Severe Acute Respiratory Syndrome Among Children
- Efficacy of interventions for prevention of chemotherapy‐induced alopecia: A systematic review and meta‐analysis
- Low-Level Light Therapy for Androgenetic Alopecia: A 24-Week, Randomized, Double-Blind, Sham Device–Controlled Multicenter Trial